Technical Note: High-content imaging of brain-on-chip microfluidic devices using PreciScan intelligent acquisition.
Brain-on-chips (BoC) are innovative tools that simulate complex brain environments, enhancing our understanding of neurodegenerative diseases (NDDs). While a range of BoC platforms have been developed to model diverse NDD pathophysiologies, the various channel architectures of these microfluidic devices present challenges in image acquisition and analysis. High-content imaging protocols must be adaptable to these differing designs. This Technical Note, developed by Revvity in collaboration with ETAP-Lab, demonstrates an automated image acquisition protocol for BoC microfluidic devices. The protocol utilizes the Operetta
Exciting research publication from our cardiology lab SYNCROSOME as co-author
Cardiovascular diseases (CVDs) are the leading cause of global mortality. That's why we are proud to share a groundbreaking study titled "Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers". Liu, Sophia et al. iScience, Volume 28, Issue 2, 111814 This study highlights the potential of Urolithin A (UA), a post-biotic and mitophagy activator, to improve heart health by addressing mitochondrial dysfunctions. Preclinical model results show reduced cardiac dysfunction, while human trials indicate significant reductions
Let’s meet at AD’s & PD’s Drug Development Summit in Boston!
We are thrilled to announce our participation in the 13th Alzheimer’s & Parkinson’s Drug Development Summit as a solution provider and preclinical CRO expert in AD's and PD's disease studies. This summit is a unique opportunity to unite new faces across biotech and pharma, capitalize on groundbreaking progress, and accelerate the development of transformative neurodegenerative therapies. 📅 If you're attending the conference, book a meeting with Jérome BERNARD who will be in Boston all the week by clicking here. Let'discover ETAP-Lab's dedicated